Cargando…
Apoptotic effect of gambogic acid in esophageal squamous cell carcinoma cells via suppression of the NF-κB pathway
Despite extensive investigations of therapeutic improvements for surgical techniques, chemotherapy and chemoradiotherapy, esophageal squamous cell carcinoma (ESCC) remains one of the most aggressive forms of cancer, and the prognosis for patients with advanced ESCC remains poor. Therefore, effective...
Autores principales: | LIU, WEN-YUE, WU, XU, LIAO, CHENG-QUAN, SHEN, JIE, LI, JUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887765/ https://www.ncbi.nlm.nih.gov/pubmed/27284372 http://dx.doi.org/10.3892/ol.2016.4437 |
Ejemplares similares
-
Gambogic acid suppresses colon cancer cell activity in vitro
por: Zhou, Zailong, et al.
Publicado: (2019) -
RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression
por: Ming, Xiao-Yan, et al.
Publicado: (2018) -
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF-κB pathway
por: Ye, Jiecheng, et al.
Publicado: (2022) -
The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
por: He, Di, et al.
Publicado: (2009) -
Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling
por: Wang, L-H, et al.
Publicado: (2014)